PIK3R1 (P27986) variants and mutations
PIK3R1 (also known as P27986) is a human protein-coding gene encoding a phosphatidylinositol 3-kinase regulatory subunit alpha protein. Its p85-family products stabilize and regulate class IA PI3K catalytic subunits and couple receptors to PI3K activation. Pathogenic variants can cause activated PI3K-delta syndrome type 2 or SHORT syndrome depending on how they alter pathway output. This analysis covers 1,967 PIK3R1 variants and mutations. Of these, 43% have computational variant effect predictions. Disease context includes SHORT syndrome, immunodeficiency 36 with lymphoproliferation, and agammaglobulinemia 7, autosomal recessive. Example PIK3R1 variants include M1?, S2R, and S2N.
Variant analysis overview
- Gene: PIK3R1
- Protein: P27986
- UniProt accession: P27986
- Organism: Homo sapiens
- Variants analyzed: 1967
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 1,776 unspecified-consequence records; 9 frameshift variants; 88 missense variants; 86 synonymous variants; 3 in-frame deletions; 2 in-frame insertions; 3 substitution
- Prediction scores: 853 variants have prediction scores (43% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: SHORT syndrome, immunodeficiency 36 with lymphoproliferation, agammaglobulinemia 7, autosomal recessive, cancer, autosomal agammaglobulinemia, activated PI3K-delta syndrome, bone development disease, endometrial cancer, isolated agammaglobulinemia, neurodegenerative disease, vascular malformation, hereditary disease.
Protein structure and variant hotspots
- Protein features: 4 domains; 6 post-translational modification sites.
- Structural context: 1,246 variants have structural context.
- PTM context: 13 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable PIK3R1 variants
Examples include M1?, S2R, S2N, S2S, A3D, A3A, A3T, A3S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV10635, cosmic curated COSV10585, NCI-TCGA Cosmic COSV5713, cosmic curated COSV57137, Variant assessed as somatic; high impact.
- S2R (p.Ser2Arg), Ensembl rs1744286765, REVEL 0.44, CADD 23.20
- S2N (p.Ser2Asn), gnomAD 5-68226680-G-A, REVEL 0.26, CADD 25.70
- S2S (p.Ser2Ser), gnomAD 5-68226681-T-C, CADD 9.59
- A3D (p.Ala3Asp), TOPMed rs1744286902, REVEL 0.32, CADD 25.00
- A3A (p.Ala3Ala), rs1447146494, gnomAD 5-68226684-T-C, CADD 4.58
- A3T (p.Ala3Thr), gnomAD 5-68239901-G-A, CADD 7.32
- A3S (p.Ala3Ser), gnomAD 5-68239901-G-T, CADD 6.83
- E4K (p.Glu4Lys), ExAC rs762586316, gnomAD rs762586316, CADD 5.43
- E4Q (p.Glu4Gln), ExAC rs762586316, gnomAD rs762586316, REVEL 0.29, CADD 25.80, Uncertain significance, Inborn genetic diseases
- E4V (p.Glu4Val), Ensembl rs2111963448, SIFT 0.00
- E4C (p.Glu4Cys), gnomAD 5-68226680-G-GTGC, CADD 29.40
- E4E (p.Glu4Glu), rs751272684, gnomAD 5-68226687-G-A, CADD 9.46
- G5E (p.Gly5Glu), ExAC rs762202728, TOPMed rs762202728, gnomAD rs762202728, REVEL 0.51, CADD 27.00
- G5V (p.Gly5Val), cosmic curated COSV10940, ExAC rs762202728, TOPMed rs762202728, gnomAD rs762202728, REVEL 0.50, CADD 26.70
- G5R (p.Gly5Arg), gnomAD 5-68226688-G-A, REVEL 0.56, CADD 28.90
- G5G (p.Gly5Gly), gnomAD 5-68226690-G-T, CADD 4.47
- Y6H (p.Tyr6His), Ensembl rs2111963517, SIFT 0.00
- Y6C (p.Tyr6Cys), gnomAD 5-68226692-A-G, REVEL 0.37, CADD 27.60
- Y6S (p.Tyr6Ser), gnomAD 5-68226692-A-C, REVEL 0.34, CADD 26.30
- Q7* (p.Gln7Ter), Ensembl rs999932649, CADD 4.28
- Q7L (p.Gln7Leu), TOPMed rs1744287849, REVEL 0.37, CADD 25.90
- Q7K (p.Gln7Lys), gnomAD 5-68239916-C-A, CADD 3.58
- Q7H (p.Gln7His), gnomAD 5-68239918-G-T, CADD 1.69
- Q7Q (p.Gln7Gln), gnomAD 5-68239918-G-A, CADD 2.09
- Y8C (p.Tyr8Cys), gnomAD rs1284153706, REVEL 0.59, CADD 28.80
- R9G (p.Arg9Gly), rs886043379, ClinGen CA10605450, ClinVar RCV000403930, Ensembl rs886043379, AlphaMissense 0.85, MetaLR 0.14, Uncertain significance, not provided
- R9K (p.Arg9Lys), cosmic curated COSV10635, Ensembl rs1744288263, REVEL 0.41, CADD 26.60
- R9R (p.Arg9Arg), gnomAD 5-68226700-A-C, CADD 5.50
- R9S (p.Arg9Ser), gnomAD 5-68226702-A-C, REVEL 0.37, CADD 23.30
- R9C (p.Arg9Cys), rs993333376, gnomAD 5-68239922-C-T, CADD 0.94
- R9H (p.Arg9His), rs1396116696, gnomAD 5-68239923-G-A, CADD 1.14
- R9L (p.Arg9Leu), rs1396116696, gnomAD 5-68239923-G-T, CADD 0.91
- R9I (p.Arg9Ile), gnomAD 5-68239935-G-T, CADD 7.62
- A10T (p.Ala10Thr), NCI-TCGA Cosmic COSV5712, cosmic curated COSV57124, SIFT 0.02, Variant assessed as somatic; moderate impact.
- A10V (p.Ala10Val), rs767837787, ClinGen CA3289922, NCI-TCGA Cosmic COSV5712, cosmic curated COSV57124, REVEL 0.41, CADD 26.00, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; SHORT syndrome; Immunodeficiency 36 w
- A10A (p.Ala10Ala), rs750929700, gnomAD 5-68226705-G-T, CADD 4.72
- L11P (p.Leu11Pro), NCI-TCGA TCGA novel, CADD 10.30, Variant assessed as somatic; moderate impact.
- L11V (p.Leu11Val), Ensembl rs2111963641, SIFT 0.02
- L11L (p.Leu11Leu), rs372754626, gnomAD 5-68226708-G-A, CADD 8.79
- L11M (p.Leu11Met), gnomAD 5-68239928-C-A, CADD 1.18
- Y12C (p.Tyr12Cys), TOPMed rs963171218, gnomAD rs963171218, REVEL 0.57, CADD 28.60, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; SHORT syndrome; Immunodeficiency 36 w
- Y12L (p.Tyr12Leu), gnomAD 5-68226708-G-GT, CADD 28.10
- D13E (p.Asp13Glu), gnomAD rs1441015747, REVEL 0.12, CADD 8.08
- D13H (p.Asp13His), cosmic curated COSV57140
- D13N (p.Asp13Asn), cosmic curated COSV99144
- D13V (p.Asp13Val), cosmic curated COSV57136, SIFT 0.17
- Y14C (p.Tyr14Cys), ExAC rs753864234, gnomAD rs753864234, SIFT 0.00
- K15Q (p.Lys15Gln), TOPMed rs1199105327, SIFT 0.28
- K15E (p.Lys15Glu), gnomAD 5-68226718-A-G, REVEL 0.24, CADD 23.60
- K15T (p.Lys15Thr), rs527933795, gnomAD 5-68239905-A-C, CADD 11.80
- K15R (p.Lys15Arg), gnomAD 5-68239905-A-G, CADD 12.10
- K15K (p.Lys15Lys), gnomAD 5-68239906-A-G, CADD 12.00
- K15N (p.Lys15Asn), gnomAD 5-68239906-A-C, CADD 11.70
- K16N (p.Lys16Asn), Ensembl rs1024194191, REVEL 0.15, CADD 24.20
- E17K (p.Glu17Lys), Ensembl rs2111963773
- E17Q (p.Glu17Gln), Ensembl rs2111963773
- E17R (p.Glu17Arg), NCI-TCGA TCGA novel, SIFT 0.01, Variant assessed as somatic; high impact.
- E17G (p.Glu17Gly), rs1316465864, gnomAD 5-68239932-A-G, CADD 7.90
- R18K (p.Arg18Lys), NCI-TCGA Cosmic COSV5713, cosmic curated COSV57134, Variant assessed as somatic; moderate impact.
- R18G (p.Arg18Gly), gnomAD 5-68226727-A-G, REVEL 0.32, CADD 23.50
- E19* (p.Glu19Ter), cosmic curated COSV10958
- E19Q (p.Glu19Gln), gnomAD 5-68226730-G-C, REVEL 0.22, CADD 26.00
- E19G (p.Glu19Gly), gnomAD 5-68226731-A-G, REVEL 0.27, CADD 24.90
- E19E (p.Glu19Glu), gnomAD 5-68226732-A-G, CADD 5.45
- E20D (p.Glu20Asp), TOPMed rs1450727380, gnomAD rs1450727380, REVEL 0.24, CADD 23.10
- E20K (p.Glu20Lys), Ensembl rs969825259
- E20Q (p.Glu20Gln), Ensembl rs969825259, SIFT 0.01
- E20del (p.Glu20del), gnomAD 5-68226728-GAGA-G, CADD 20.40
- D21V (p.Asp21Val), rs2111963818, ClinGen CA359979486, ClinVar RCV001769296, ClinVar RCV006557679, REVEL 0.61, CADD 27.50, Uncertain significance, SHORT syndrome; Immunodeficiency 36 with lymphoproliferation; Agammaglobulinemia
- D21D (p.Asp21Asp), rs755062301, gnomAD 5-68226738-T-C, CADD 9.86
- I22T (p.Ile22Thr), rs150689648, ClinGen CA3289928, cosmic curated COSV57126, ClinVar RCV000535880, REVEL 0.45, CADD 26.60, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; SHORT syndrome; Immunodeficiency 36 w
- I22V (p.Ile22Val), gnomAD 5-68226739-A-G, REVEL 0.19, CADD 23.20
- I22I (p.Ile22Ile), gnomAD 5-68226741-T-C, CADD 7.97
- D23V (p.Asp23Val), TOPMed rs1744290265
- D23G (p.Asp23Gly), gnomAD 5-68226743-A-G, REVEL 0.38, CADD 26.90
- D23D (p.Asp23Asp), gnomAD 5-68226744-C-T, CADD 9.90
- L24F (p.Leu24Phe), TOPMed rs1206337660, gnomAD rs1206337660, REVEL 0.25, CADD 23.90
- L24V (p.Leu24Val), ExAC rs748433931, gnomAD rs748433931, REVEL 0.27, CADD 22.80
- L24W (p.Leu24Trp), ExAC rs770742875, gnomAD rs770742875, REVEL 0.48, CADD 27.80
- H25Q (p.His25Gln), ExAC rs745790934, TOPMed rs745790934, gnomAD rs745790934, SIFT 0.59
- H25Y (p.His25Tyr), ExAC rs780894850, gnomAD rs780894850, REVEL 0.17, CADD 16.40
- H25H (p.His25His), rs745790934, gnomAD 5-68226750-C-T, CADD 9.54
- L26* (p.Leu26Ter), cosmic curated COSV10727
- L26F (p.Leu26Phe), cosmic curated COSV99161, TOPMed rs1001383254, gnomAD rs1001383254, REVEL 0.07, CADD 24.00
- L26L (p.Leu26Leu), rs1001383254, gnomAD 5-68226753-G-A, CADD 10.10
- G27C (p.Gly27Cys), NCI-TCGA TCGA novel, Ensembl rs2111963939, Variant assessed as somatic; moderate impact.
- G27D (p.Gly27Asp), Ensembl rs2111963959
- G27R (p.Gly27Arg), Ensembl rs2111963939, SIFT 0.00
- G27S (p.Gly27Ser), Ensembl rs2111963939, REVEL 0.53, CADD 28.10
- G27V (p.Gly27Val), NCI-TCGA Cosmic COSV9914, cosmic curated COSV99143, REVEL 0.59, CADD 25.10, Variant assessed as somatic; moderate impact.
- D28N (p.Asp28Asn), gnomAD 5-68226757-G-A, REVEL 0.42, CADD 29.00
- D28D (p.Asp28Asp), rs868241006, gnomAD 5-68226759-C-T, CADD 7.44
- I29V (p.Ile29Val), gnomAD 5-68226760-A-G, REVEL 0.05, CADD 7.94
- L30L (p.Leu30Leu), rs2111963982, gnomAD 5-68226763-T-C, CADD 5.11
- T31I (p.Thr31Ile), Ensembl rs2111963987
- T31N (p.Thr31Asn), Ensembl rs2111963987
- T31S (p.Thr31Ser), Ensembl rs2111963987
- T31T (p.Thr31Thr), gnomAD 5-68226768-T-C, CADD 10.60
- V32M (p.Val32Met), Ensembl rs2111964008, SIFT 0.00
- N33S (p.Asn33Ser), gnomAD 5-68226773-A-G, REVEL 0.11, CADD 17.50
- N33N (p.Asn33Asn), rs1744811255, gnomAD 5-68239921-C-T, CADD 8.03
- K34K (p.Lys34Lys), rs972251443, gnomAD 5-68226777-A-G, CADD 11.40
- G35A (p.Gly35Ala), rs1017086766, ClinGen CA120629741, ClinVar RCV001891579, ClinVar RCV002293538, REVEL 0.11, CADD 17.80, Uncertain significance, SHORT syndrome; Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 w
- G35D (p.Gly35Asp), rs2530796781, ClinGen CA2580073384, ClinVar RCV003041503, Uncertain significance, SHORT syndrome; Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 w
- G35E (p.Gly35Glu), TOPMed rs1017086766, gnomAD rs1017086766, REVEL 0.19, CADD 25.70, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; SHORT syndrome; Immunodeficiency 36 w
- G35K (p.Gly35Lys), NCI-TCGA TCGA novel, SIFT 0.00, Variant assessed as somatic; high impact.
- G35G (p.Gly35Gly), rs769581765, gnomAD 5-68226780-G-A, CADD 6.93
- S36C (p.Ser36Cys), Ensembl rs2111964064
- S36F (p.Ser36Phe), Ensembl rs2111964064
- S36S (p.Ser36Ser), rs775593894, gnomAD 5-68226783-C-A, CADD 8.17
- V38L (p.Val38Leu), ExAC rs762496756, gnomAD rs762496756, REVEL 0.05, CADD 10.60
- A39D (p.Ala39Asp), Ensembl rs2111964123
- A39T (p.Ala39Thr), Ensembl rs2111964110, SIFT 0.14
- L40P (p.Leu40Pro), rs2111964134, ClinGen CA359979612, ClinVar RCV001874136, Ensembl rs2111964134, AlphaMissense 0.83, MetaLR 0.06, Uncertain significance, SHORT syndrome; Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 w
- G41A (p.Gly41Ala), ESP rs370778654, TOPMed rs370778654, REVEL 0.25, CADD 25.60
- G41R (p.Gly41Arg), gnomAD 5-68226796-G-A, REVEL 0.48, CADD 28.40
- F42C (p.Phe42Cys), cosmic curated COSV10585, SIFT 0.54
- F42V (p.Phe42Val), rs1450313327, gnomAD rs1450313327, REVEL 0.20, CADD 22.00, Variant assessed as somatic; moderate impact.
- S43G (p.Ser43Gly), rs962529901, TOPMed rs962529901, gnomAD rs962529901, REVEL 0.03, CADD 20.40, Variant assessed as somatic; moderate impact.
- S43R (p.Ser43Arg), cosmic curated COSV10585, cosmic curated COSV99140, SIFT 0.21
- G45R (p.Gly45Arg), gnomAD 5-68226808-G-A, REVEL 0.54, CADD 29.10
- Q46* (p.Gln46Ter), cosmic curated COSV99075
- E47K (p.Glu47Lys), ESP rs373560990, ExAC rs373560990, TOPMed rs373560990, gnomAD rs373560990, REVEL 0.35, CADD 29.40
- E47Q (p.Glu47Gln), ESP rs373560990, ExAC rs373560990, TOPMed rs373560990, gnomAD rs373560990, REVEL 0.27, CADD 27.00
- p.Glu47dup, rs1307114189, gnomAD 5-68226813-G-GGAA, CADD 21.20
- A48G (p.Ala48Gly), TOPMed rs1361328385, gnomAD rs1361328385, REVEL 0.08, CADD 23.40
- A48T (p.Ala48Thr), cosmic curated COSV10585, ExAC rs774143442, TOPMed rs774143442, gnomAD rs774143442, REVEL 0.08, CADD 22.80, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; SHORT syndrome; Immunodeficiency 36 w
- A48V (p.Ala48Val), TOPMed rs1361328385, gnomAD rs1361328385, REVEL 0.08, CADD 23.40, Likely benign, PIK3R1-related immunodeficiency and SHORT syndrome
- R49S (p.Arg49Ser), cosmic curated COSV10876
- R49T (p.Arg49Thr), TOPMed rs1311708045, gnomAD rs1311708045, REVEL 0.10, CADD 18.90, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; SHORT syndrome; Immunodeficiency 36 w
- R49R (p.Arg49Arg), rs755197186, gnomAD 5-68226822-G-A, CADD 9.70
- P50T (p.Pro50Thr), gnomAD 5-68226823-C-A, REVEL 0.45, CADD 25.10
- P50L (p.Pro50Leu), gnomAD 5-68226824-C-T, REVEL 0.49, CADD 26.50
- P50S (p.Pro50Ser), rs1158240702, gnomAD 5-68239910-C-T, CADD 8.32
- E51G (p.Glu51Gly), Ensembl rs1561258126, REVEL 0.15, CADD 23.10
- E51K (p.Glu51Lys), rs2111964278, ClinGen CA359979681, ClinVar RCV002304876, REVEL 0.16, CADD 23.10, Uncertain significance, Immunodeficiency 36 with lymphoproliferation; Agammaglobulinemia 7, autosomal re
- E51Q (p.Glu51Gln), Ensembl rs2111964278
- E52* (p.Glu52Ter), NCI-TCGA Cosmic COSV5712, cosmic curated COSV57124, Variant assessed as somatic; high impact.
- E52K (p.Glu52Lys), Ensembl rs2111964308, SIFT 0.13
- E52D (p.Glu52Asp), gnomAD 5-68226831-A-T, REVEL 0.09, CADD 14.50
- I53T (p.Ile53Thr), rs1561258129, ClinGen CA359979702, ClinVar RCV004505884, ClinVar RCV006564807, REVEL 0.28, CADD 26.00, Uncertain significance, Inborn genetic diseases; Immunodeficiency 36 with lymphoproliferation; Agammaglo
- I53V (p.Ile53Val), rs2530796951, ClinGen CA359979698, ClinVar RCV002797103, REVEL 0.12, CADD 19.20, Uncertain significance, SHORT syndrome; Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 w
- I53I (p.Ile53Ile), gnomAD 5-68226834-T-A, CADD 6.98
- G54D (p.Gly54Asp), gnomAD rs1343380312, REVEL 0.49, CADD 27.60
- G54V (p.Gly54Val), gnomAD rs1343380312, SIFT 0.00
- W55* (p.Trp55Ter), Ensembl rs2111964362
- L56V (p.Leu56Val), gnomAD rs1580173658, REVEL 0.20, CADD 22.60
- L56L (p.Leu56Leu), gnomAD 5-68226841-T-C, CADD 8.65
- N57S (p.Asn57Ser), rs1580173662, ClinGen CA359979730, ClinVar RCV000818495, Ensembl rs1580173662, AlphaMissense 0.06, MetaLR 0.01, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 with lymphoprolif
- G58A (p.Gly58Ala), Ensembl rs2111964436
- G58S (p.Gly58Ser), TOPMed rs918282505, SIFT 0.00
- G58G (p.Gly58Gly), gnomAD 5-68226849-C-T, CADD 10.30
- Y59C (p.Tyr59Cys), cosmic curated COSV57137, ExAC rs761431445, gnomAD rs761431445, REVEL 0.10, CADD 22.90, Uncertain significance, Inborn genetic diseases
- Y59F (p.Tyr59Phe), gnomAD 5-68226851-A-T, REVEL 0.14, CADD 15.00
- Y59Y (p.Tyr59Tyr), rs1279964790, gnomAD 5-68226852-T-C, CADD 8.51
- E61D (p.Glu61Asp), rs2530797021, ClinGen CA359979761, ClinVar RCV003797255, Uncertain significance, SHORT syndrome; Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 w
- T62I (p.Thr62Ile), rs1744294827, ClinGen CA359979765, ClinVar RCV001203218, Ensembl rs1744294827, AlphaMissense 0.16, MetaLR 0.02, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; SHORT syndrome; Immunodeficiency 36 w
- T62S (p.Thr62Ser), Ensembl rs1744294827, SIFT 0.55, Uncertain significance
- T63I (p.Thr63Ile), ExAC rs767892340, gnomAD rs767892340, SIFT 0.01
- T63P (p.Thr63Pro), gnomAD rs1444581630, REVEL 0.43, CADD 27.10
- T63S (p.Thr63Ser), gnomAD rs1444581630, REVEL 0.37, CADD 25.50
- T63T (p.Thr63Thr), rs2111964548, gnomAD 5-68226864-A-G, CADD 1.59
- E65K (p.Glu65Lys), Ensembl rs2111964583, REVEL 0.35, CADD 27.00
- E65E (p.Glu65Glu), rs73768883, gnomAD 5-68226870-A-G, CADD 8.38
- R66K (p.Arg66Lys), rs761122171, ClinGen CA3289941, cosmic curated COSV99075, ClinVar RCV000506810, REVEL 0.12, CADD 19.40, Uncertain significance, not specified
- R66S (p.Arg66Ser), ExAC rs766811997, TOPMed rs766811997, gnomAD rs766811997, REVEL 0.20, CADD 23.10, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 with lymphoprolif
- R66T (p.Arg66Thr), gnomAD 5-68226872-G-C, REVEL 0.18, CADD 25.30
- R66R (p.Arg66Arg), rs766811997, gnomAD 5-68226873-G-A, CADD 8.90
- G67E (p.Gly67Glu), rs1744296159, ClinGen CA359979796, ClinVar RCV001223412, Ensembl rs1744296159, REVEL 0.92, CADD 27.10, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; SHORT syndrome; Immunodeficiency 36 w
- G67R (p.Gly67Arg), cosmic curated COSV10509, SIFT 0.00
- G67G (p.Gly67Gly), rs754345200, gnomAD 5-68226876-G-A, CADD 4.72
- D68E (p.Asp68Glu), gnomAD rs1298997052, REVEL 0.13, CADD 24.50
- D68G (p.Asp68Gly), Ensembl rs1580173730
- D68H (p.Asp68His), rs755043940, ClinGen CA3289944, ClinVar RCV001361547, ClinVar RCV004952815, REVEL 0.39, CADD 27.00, Uncertain significance, Immunodeficiency 36 with lymphoproliferation; Agammaglobulinemia 7, autosomal re
- D68N (p.Asp68Asn), rs755043940, ClinGen CA3289945, ClinVar RCV000545810, ClinVar RCV005252957, REVEL 0.29, CADD 28.10, Uncertain significance, Agammaglobulinemia 7, autosomal recessive; SHORT syndrome; Immunodeficiency 36 w
- D68Y (p.Asp68Tyr), ExAC rs755043940, TOPMed rs755043940, gnomAD rs755043940, SIFT 0.00, Uncertain significance
- D68A (p.Asp68Ala), gnomAD 5-68226878-A-C, REVEL 0.36, CADD 27.70
- F69L (p.Phe69Leu), rs752891021, ClinGen CA3289946, ClinVar RCV003795818, ClinVar RCV005629993, REVEL 0.41, CADD 28.20, Uncertain significance, SHORT syndrome; Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 w
- P70A (p.Pro70Ala), Ensembl rs2111964830, SIFT 0.01
Public PIK3R1 analysis runs
- PIK3R1 analysis run — PIK3R1 (1,967 variants) — completed 2026-08-18